Home » Topics » Regulatory » Patents

Patents
RSS

Abbott discloses 5-lipoxygenase inhibitors

June 28, 1996

Leukotriene biosynthesis inhibitors from Merck Frosst

June 28, 1996

Suntory describes metabotropic glutamate antagonists

June 28, 1996

RPR reports glutamate antagonists

June 28, 1996

NMDA antagonists synthesized by Hoechst Marion Roussel

June 28, 1996

Protein kinase inhibitors reported by Cephalon

June 28, 1996

Brain monoamine partial agonists/antagonists claimed by Neurogen

June 28, 1996

Apolipoprotein B synthesis inhibitors reported

June 28, 1996

Potential photodynamic therapy described

June 28, 1996

Antineoplastic/antifungal agent revealed

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...